NCT04607824

Brief Summary

HRV is attained using a Polar RS800CX. Then, evaluated through linear, non-linear and chaotic global techniques (CGT). Forty-five male subjects were included in the DMD group and age-matched with forty-five in the healthy Typical Development (TD) control group. They were assessed for twenty minutes at rest sitting, and then five minutes whilst performing the maze task on a computer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2014

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
5.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 22, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 29, 2020

Completed
Last Updated

October 29, 2020

Status Verified

October 1, 2020

Enrollment Period

9 months

First QC Date

October 22, 2020

Last Update Submit

October 22, 2020

Conditions

Keywords

Heart rate variabilityDuchenne muscular dystrophyTypically developedAutonomic nervous systemChaotic global techniques

Outcome Measures

Primary Outcomes (1)

  • Heart Rate Variability behavior during computational task

    Linear, non-linear and complexity indices of heart rate variability will be assessed at rest and during computational task, in order to analyse it's behavior.

    1 day

Study Arms (2)

Duchenne Muscular Dystrophy group

Forty-five male subjects were included in the Duchenne Muscular Dystrophy (DMD) group and they were assessed for twenty minutes at rest sitting, and then five minutes whilst performing the maze task on a computer.

Behavioral: Duchenne Muscular Dystrophy group

Typical Development group

Forty-five male subjects were included in the healthy Typical Development (TD) control group and they were assessed for twenty minutes at rest sitting, and then five minutes whilst performing the maze task on a computer

Behavioral: Typical Development group

Interventions

Assessment of heart rate variability at rest and during computational task in people with Duchenne muscular dystrophy

Duchenne Muscular Dystrophy group

Assessment of heart rate variability at rest and during computational task in people with typical Development

Typical Development group

Eligibility Criteria

Age9 Years - 21 Years
Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

45 individuals with DMD (convenience sample) and 45 age-matched healthy TD individuals participated in the trial.

You may qualify if:

  • DMD diagnoses was based on molecular methods and/or muscular protein expression.
  • TD age-matched with DMD.

You may not qualify if:

  • subjects with severely dilated myocardium.
  • subjects with other associated diseases.
  • individuals with inability to understand task instructions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Comitê de ética da Faculdade de Medicina da Universidade de São Paulo

São Paulo, São Paulo, 01246903, Brazil

Location

MeSH Terms

Conditions

Muscular Dystrophy, Duchenne

Condition Hierarchy (Ancestors)

Muscular DystrophiesMuscular Disorders, AtrophicMuscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesGenetic Diseases, X-LinkedGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Carlos BM Monteiro, Ph.D.

    University of Sao Paulo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 22, 2020

First Posted

October 29, 2020

Study Start

March 1, 2014

Primary Completion

December 1, 2014

Study Completion

June 1, 2020

Last Updated

October 29, 2020

Record last verified: 2020-10

Locations